S epsis and septic shock remain major causes of morbidity and mortality worldwide with reported mortality rates of 10% to 50% (1-4). An important feature in the pathophysiology of septic shock is the development of progressive hemodynamic and cardiovascular instability and depressed myocardial contractility (5, 6).
Meningococcal septicemia is among the most fulminant causes of septic shock and is a major infectious cause of death in children in many developed countries. Because meningococcal sepsis generally occurs in otherwise healthy children and adults, it provides a unique model to study the mechanisms of septic shock. We previously showed that interleukin 6 (IL-6) is a major myocardial depressant factor in meningococcal shock (12) .
IL-6 induces a wide range of cellular and physiological responses (13) . On binding to its receptor, IL-6 causes homodimerization of the membrane-bound receptor gp130, which in turn leads to activation of associated protein tyrosine kinases, including the Janus kinase (JAK) family (14) , tyrosine phosphorylation of gp130 (15) , and activation of multiple signal transducing factors such as signal transducer and activator of transcription (STAT) (16) . After phosphorylation, STATs migrate to the nucleus where they upregulate transcription of a number of intracellular signaling cascades. The p38 mitogen-activated protein kinase (MAPK) (17) and phosphatidylinositol 3-kinase (PI3K) (18) pathways are known to be activated in cardiac myocytes after inflammatory activation. The functional significance of these intracellular signaling pathways in the context of IL-6-mediated negative inotropy in sepsis is not well defined. We set out to investigate the role of key downstream signaling mediators in the myocardial depression induced by IL-6.
METHODS
We undertook a series of in vitro and in vivo studies to explore the pathway of IL-6-induced myocardial depression in meningococcal sepsis (Fig. 1) .
Patients and Control Subjects. Children were enrolled in the study at the time of admission to the intensive care unit with suspected meningococcal sepsis. After informed parental consent, and with approval of the hospital local research ethics committee, venous blood was collected on admission to the pediatric intensive care unit. Diagnosis was confirmed by isolation of the organism from blood, cerebrospinal fluid, or by polymerase chain reaction amplification of meningococcal DNA from peripheral blood, as described previously (19) . Venous blood samples from healthy adult volunteers were obtained after informed consent.
Biological and Chemical Reagents. Antibodies to p38MAPK, phospho-p38MAPK, Akt, phospho-Akt, STAT3, and phospho-STAT3 were obtained from Cell Signaling Technology (Danvers, MA). IL-6 was obtained from Biomyx Technology (San Diego, CA). All other chemicals were purchased from Sigma-Aldrich (Gillingham, UK).
Isolation of Adult Rat and Human Ventricular Myocytes. All studies complied with the United Kingdom Home Office Regulation Governing the Care and Use of Laboratory Animals. Ventricular myocytes were isolated from adult male Sprague-Dawley rats (Imperial College, London, UK) (250 -350 g) by collagenase digestion using the standard enzymatic technique as previously described (12) .
Human tissue from the left or right ventricle was obtained from explanted hearts in adult patients undergoing cardiac transplantation after informed consent. Procedures for collecting human heart tissue conformed to the ethics committee requirements of the Royal Brompton and Harefield Hospital. Tissue was immediately placed in cardioplegia solution at 4°C and ventricular myocytes isolated using a standard enzymatic technique (12) .
For adenoviral transfection, cells were infected with adenovirus at a multiplicity of infection of 500 for the dominant negative p38MAPK (Ad. dominant negative p38MAPK) construct, which had the phosphorylation motif (T-G-Y) mutated to (A-G-F) (kindly provided by Drs Menick, Charleston, and Wang, University of California, San Diego, CA). Cells were incubated at 37°C for 48 hrs before use in myocyte contraction assays.
Myocyte Contraction Measurements. Myocyte contraction experiments were performed as previously described (12) . In brief, cells in Kerbs-Henseleit solution equilibrated to pH 7.4 with 95% O 2 -5% CO 2 were placed in a Perspex chamber on the stage of an inverted microscope. Myocytes were left for 10 mins to allow time for adherence to the coverslip. After this time, cells were perfused with KerbsHenseleit solution supplemented with calcium (1-2 mM, rat; 2-6 mM, human). Experiments were carried out at 37°C with field stimulation at 0.5 Hz in rat myocytes, whereas human myocytes were paced at 0.2 Hz, 32°C. Individual cells were digitally tracked and the contraction amplitude measured continually using video edge detection as previously described (12) (Ionoptix, Milton, MA). Myocyte contraction was expressed as the percentage shortening of cell length on field stimulation.
Analysis of the IL-6 Signaling Pathway Using Inhibitors of Key Intracellular Mediators.
To obtain a model that closely resembled the clinical situation of septic shock, in which patients are supported with inotropic medication, we used catecholamine stimulation. Isoprenaline (10 nM) was added to perfusion buffer and a baseline measurement taken when contraction amplitude reached a stable plateau.
For evaluation of PI3K, JAK2, and p38MAPK, cells were perfused with the specific inhibitors (10 M LY94002, 20 M AG490, 3 M SB203580, respectively) for 15 mins before exposure to To evaluate the role of G i signaling, isolated rat ventricular myocytes were incubated with 1.5 g/mL pertussis toxin (an inhibitor of this pathway) for 24 hrs and then used in contraction assays. For individual myocytes, the efficiency of G i inactivation was confirmed by carbachol challenge in the presence of isoprenaline.
Western Blotting. Western blotting was performed to identify and quantify STAT3, Akt, and p38MAPK protein levels. We also used this method to examine p38MAPK activation in dominant negative myocytes. Cultured myocytes were centrifuged (14,000 g, 10 mins, 4°C), snap-frozen in liquid nitrogen, and stored at Ϫ80°C. Cells were subsequently resuspended in Phospho-Safe extraction buffer (Novagen) and protein concentrations determined (Bio-Rad). Using a 10% gel, 40 g of protein was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to polyvinylidene fluoride mem- Figure 1 . Experimental approach to studying the pathway of interleukin 6 (IL-6)-induced myocardial depression. We used both an in vitro model of cardiac function to explore the mediators activated by IL-6 (A) and blood samples from children with meningococcal sepsis to examine changes in the regulation of the p38 mitogen-activated protein kinase (MAPK) pathway (B).
brane. Blots were incubated with antibodies to the target mediator overnight at 4°C. Secondary antibodies were either conjugated with horseradish peroxidase (Amersham Pharmaceuticals, Amersham, UK) or fluorescence (QDot) to detect protein bands. Protein levels were quantified using densitometry (Gene Genius Gel Imaging; Syngene, Cambridge, UK).
Gene Expression. Whole blood (2.5 mL) from patients and control subjects was collected into RNA stabilization fluid (PaxGene Blood RNA tubes; Becton Dickinson). Patient samples were obtained on admission to the intensive care unit within 24 hrs of clinical presentation. Total RNA was extracted using PreAnalytix RNA extraction kit (Qiagen, Crawley, UK).
After linear amplification (MessageAmp II; Applied Biosystems, Carlsbad, CA), and reverse transcription to complementary DNA, sample complementary DNA was labeled with Cy5-2=-deoxyuridine 5=-triphosphate and combined with Cy3-2=-deoxyuridine 5=-triphosphatelabeled reference complementary DNA (Stratagene, Santa Clara, CA) (20) . Samples were then washed, concentrated, and hybridized to custom-printed cDNA microarrays containing 37,632 elements representing approximately 18,000 unique human genes (21) . The hybridized slides were scanned using a GenePix 4000A microarray scanner (Axon Instruments, Sunnyvale, CA) with every spot on the array given a relative fluorescence ratio for sample and reference RNA. Areas of the array with blemishes or poor quality were excluded from analysis using GenePix Pro 6.0 (Axon Instruments).
For the rat microarray experiment, isolated cardiac ventricular myocytes were cultured in M199 medium with addition of 5 mM creatine, 5 mM taurine, 2 mM carnitine, 0.1 M insulin, 100 mM ascorbate, and penicillin/ streptomycin. Cells were incubated with recombinant human IL-6 (20 ng/mL) or in medium alone for 6 hrs at 37°C. Myocyte RNA was extracted using the RNEasy extraction kit (Qiagen). RNA was amplified and labeled using the Illumina TotalPrep RNA Amplification Kit (Applied Biosystems) and hybridized to the RatRef-12 Expression BeadChip (Illumina, San Diego, CA). Arrays were scanned using a BeadArray Reader (Illumina) and probe IDs associated with intensity data using BeadStudio version 3.1.3.0 (Illumina).
The data sets discussed in this publication have been deposited in the Stanford Microarray Database and Array Express under accession number E-MTAB-344.
Statistics. All quantitative data are expressed as median Ϯ interquartile range. Continuous data were analyzed using the Wilcoxon signed rank test to compare control and experimental conditions. A value of p Ͻ .05 was considered statistically significant.
Raw expression data from 37 individuals (23 healthy control subjects, 14 patients) were downloaded from Stanford Microarray Database (22) .
Data were filtered to include array elements that were present on Ͼ80% of the arrays. Within-slide normalization was performed through within-print tip group intensity dependent location normalization using the loess function to correct for systematic variation that is introduced by the overall spot intensity, dye, and spatial effects. Scale normalization was applied to equalize the range of log 2 ratios between slides. Differential expression analysis followed a "Two-Groups: Common Reference" experimental design and was performed using Limma (23) . Linear models were fitted and moderated t statistics were calculated for each gene. Adjustment for multiple hypothesis testing was performed through the Benjamini and Hochberg method that controls the false discovery rate (24) . The significance level was set to ␣ ϭ 0.05. Enrichment of the p38MAPK pathway was assessed by the hypergeometric distribution (Fisher's exact). The analysis was conducted with the use of Bioconductor software packages in R (25) .
To investigate the role of p38MAPK in the clinical pathophysiology of meningococcal sepsis, we used whole genome RNA expression profiling to study the regulation of activators and downstream effectors of p38MAPK. We identified genes widely accepted as being part of the p38MAPK signaling pathway using KEGG (26) Panther version 6.1 (27) , Ingenuity Pathways Analysis 6, and GeneAssist Pathway Atlas (http://www.ambion.com) as well as published literature and Web sites (26, 28 -32) (http://www.cellsignal.com).
RESULTS
Patients. There were 14 children (2 months to 16 yrs of age) included in the study; eight children were female and six were male. Median age was 51 months (interquartile range, 21-157 months). There were two deaths (14.3%). All patients had clinical evidence of meningococcal septicemia with petechiae or purpura. Some had additional signs or symptoms of meningitis.
IL-6 Reduces Both Basal Cardiac Myocyte Contractility and Inotrope Responsiveness. Addition of 20 ng/mL IL-6 (the median serum level of IL-6 seen in our patients in a previous study [12] ) to the perfusion buffer not only acutely depressed basal myocyte contraction as previously shown, but significantly diminished inotrope sensitivity. After establishing baseline myocyte contractility for 15 mins, addition of isoprenaline (30 nM) to the perfusion buffer increased myocyte contraction amplitude by 52%: from 6.1% (interquartile range [IQR], 3.9 -8.5) to 9.3% (IQR, 6.7-11.7; n ϭ 45). After 15 mins, IL-6 was added to the perfusion buffer, significantly decreasing myocyte contraction by 19.9% to 7.45% (IQR, 6.0 -9.6), n ϭ 45 ( Fig. 2A) . This inotrope insensitivity persisted for at least 15 mins after IL-6 was removed from the perfusion buffer.
We previously showed meningococcal serum had both acute and latent myocardial depressant effects (33) . Similarly, IL-6 significantly reduced contraction amplitude of cardiac myocytes after incubation (48 hrs) with a median (IQR) percentage change in contraction amplitude of Ϫ24.2% (Ϫ4.9 to Ϫ56.3) compared with control cells (n ϭ 14, p ϭ .03).
JAK2 and PI3K/Akt Are Involved in IL-6-Induced Negative Inotropy. Activation of JAK/STAT signaling has previously been associated with gp130-related stimulation by IL-6 in adult ventricular cardiac myocytes (16) . Addition of AG490 (a specific inhibitor of JAK 2) to the perfusion buffer reduced the negative inotropic effect of IL-6 on isoprenaline-stimulated myocytes: median (IQR) change in contraction amplitude of Ϫ9.8% (Ϫ22.5% to Ϫ2) (control) to Ϫ0.85% (Ϫ18.5% to 10.2%; n ϭ 9) (JAK2-inhibited), although the change was not statistically significant (Fig. 2B) . Furthermore, STAT3 phosphorylation was not significantly increased. Median (IQR) ratio of phosphorylated to total STAT3 in control cells was 0.381 (0.17-0.60) and in IL-6-exposed cells was 0.39 (0.22-0.93; n ϭ 10; p ϭ .06). This suggests that pathways other than JAK/STAT may be involved.
Several groups have implicated PI3K in the negative regulation of cardiac contractility (18, 34) . In agreement with these previous findings, we found that the PI3K inhibitor LY294008 ablated the myocardial depressant effect of IL-6. Control cells had a median (IQR) change of Ϫ17.8% (Ϫ46.6 to Ϫ8.2; n ϭ 6) in contraction amplitude, whereas pretreatment of myocytes with LY294008 resulted in no significant change (median, 0.1; IQR, Ϫ6.8 to 5.8) in contraction amplitude after exposure to IL-6 (n ϭ 5) (Fig. 2B ). In addition, in myocytes exposed to IL-6, phosphorylation of Akt, a downstream signaling protein in the PI3K pathway, was increased by 1.5-fold over control cells (Fig. 2C) .
p38MAPK Regulates Inotrope Insensitivity in IL-6-Exposed Myocytes. We used the p38MAPK inhibitor, SB203580, to in-vestigate the role of p38MAPK in IL-6-induced negative inotropy. Pretreatment with SB203580 not only inhibited IL-6-induced myocardial depression, but restored isoprenaline responsiveness in both rat and human myocytes (Fig. 1D) . In rat myocytes, a reduction in contractility of control cells (median, Ϫ15%; IQR, Ϫ27.7% to Ϫ5.7%) compared with isoprenaline alone was converted to an (median, 5.6%; IQR, Ϫ3% to 56.5%) increase in contractility in response to IL-6 in SB203580-exposed cells (again compared with contractility with isoprenaline alone) (n ϭ 8). In human myocytes, IL-6 reduced myocyte contractility (median, Ϫ27.4; IQR, Ϫ41.8 to 0.8), but SB203580 pretreatment led to a median increase in contraction amplitude of 107.1 (IQR, 93.5-116.1) after IL-6-exposure (n ϭ 7). There was no effect of any of the inhibitors on basal myocyte contraction amplitude or on the response to isoprenaline (data not shown). This is to our knowledge the first study to demonstrate in human cardiac myocytes that inhibition of p38MAPK reverses IL-6-mediated contractile depression. Indeed, in the absence of p38MAPK activity, IL-6 had a paradoxic effect and increased myocyte contractility.
To confirm the key role of the p38MAPK pathway in the negative inotropy of IL-6, rat myocytes were transfected with an adenovirus encoding a dominant negative p38MAPK to reduce p38MAPK activity. Western blotting confirmed that transduced cells showed greatly reduced p38MAPK phosphorylation, although a small amount of residual p38MAPK phosphorylation was retained (data not shown). Dominant negative p38MAPK myocytes were also resistant to the negative inotropy of IL-6 (Fig. 2D) . In control cells, IL-6 exposure reduced contraction amplitude (median, Ϫ13.1; IQR, Ϫ29 to Ϫ2.9). In dominant negative p38MAPK myocytes, IL-6 induced no significant change in contraction amplitude (median, 5.35%; IQR, Ϫ9.7% to 10.7%; n ϭ 10), confirming the importance of p38MAPK in the myocardial depressant activity of IL-6.
Finally, we investigated changes in gene expression of the p38MAPK pathway in cardiac myocytes exposed to IL-6. Adult rat ventricular myocytes were cultured with recombinant human IL-6 for a period of 6 hrs; 740 genes were significantly differentially expressed (fold change of treated cells compared with control cells of p Ͻ .05) (Supplemental Table 1 [see Supplemental Digital Content 1, http://links.lww.com/CCM/A243]). Of these, eight genes belonged to the p38-MAPK pathway (of 115 MAPK-associated genes represented on the array). The hypergeometric probability of this occurring by chance was p ϭ .004. Table 1 lists these genes, their log-fold changes, and p values. Taken together, our data establish an important functional role for p38MAPK signaling in the negative inotropic activity of IL-6. It is interesting to note that in the absence of p38MAPK activity, the net effect of IL-6 on rat myocytes was positive inotropy.
p38MAPK Is Highly Dysregulated in Children With Meningococcal Sepsis. As shown in Figure 3 , a large proportion of genes of the p38MAPK pathway were significantly differentially expressed in children with meningococcal septicemia compared with healthy controls. Hierarchical clustering of p38 MAPK genes and subjects showed that patients and control subjects showed significant differentiation in the levels of expression of p38MAPK pathway genes (Fig. 4A ). Of the 150 MAPK genes on the array, 115 were differentially expressed. To examine those genes of this pathway that best discriminated patients from control subjects, we displayed the data on a volcano plot as demonstrated in Figure 4B . p38MAPK␣ (MAPK14), the isoform most commonly associated with negative inotropy, had a high log odds (17.54) and significance (adjusted p ϭ 7.88 ϫ 10 Ϫ10 ) in patients compared with healthy control subjects. In addition, a large number of genes upstream and downstream of p38MAPK showed significant differential expression in children with severe meningococcal infection on admission to intensive care, relative to expressed levels of these genes in healthy control subjects (Fig. 4A-B Pathway analysis of interleukin 6 (IL-6)-mediated cardiac dysfunction. Janus kinase 2 (JAK2), phosphatidylinositol 3-kinase (PI3K), Akt, and p38 mitogen-activated protein kinase (MAPK) modulate the negative inotropic response of cardiac myocytes to IL-6. A, Acute effect of IL-6 on cardiac myocyte contractility. Measurements were taken in the presence of perfusion buffer alone (baseline) and then after addition of 30 nM isoprenaline to the buffer (isoprenaline stimulation), addition of 20 ng/mL IL-6 to the perfusion buffer (addition of IL-6), and removal of IL-6 from the buffer (IL-6 washout). B, Role of JAK2 and PI3K in IL-6-induced myocyte contractile depression. The difference in contractility of cardiac myocytes in the presence of isoprenaline and IL-6 was measured with and without a JAK2 or PI3K inhibitor. IL-6 depressed contractility, and this depression was reversed by inhibition of JAK2 using AG490 or by inhibition of PI3K using LY294008. C, IL-6 increases phosphorylation of Akt in rat cardiac myocytes. Western blots demonstrate increased phosphorylation of AkT (pAkt) in rat cardiac myocytes incubated with IL-6 compared with control cells. D, Role of p38MAPK in IL-6-induced myocyte contractile depression. Inhibition of p38MAPK using SB203580 not only reversed the negative inotropic effect of IL-6 in both rat (i) and human (ii) cardiac myocytes, but a positive inotropic activity was seen in response to IL-6 in these cells. In addition, in p38 dominant negative myocytes, the effect of IL-6 was significantly diminished.
genes of the p38MAPK pathway, genes that encode members of the p38MAPK pathway that are significantly overexpressed in meningococcal patients as compared with healthy children; Supplementary Fig. 1B [see Supplemental Digital Content 3, http://links.lww.com/CCM/A245], which displays downregulated genes of the p38MAPK pathway, genes that encode members of the p38MAPK pathway that are significantly underexpressed in meningococcal patients as compared with healthy children; Supplementary Table  2 [see Supplemental Digital Content 4, http://links.lww.com/CCM/A246]). The probability that this group of p38MAPK genes was differentially expressed by chance was 2.12 ϫ 10e-11 (calculated using the hypergeometric distribution), which strongly supports the hypothesis that the differential regulation of the p38MAPK pathway, is a key feature of meningococcal sepsis.
DISCUSSION
Interleukin 6 is an established mediator of organ dysfunction in septic shock. We and others have highlighted the role of IL-6 in the pathogenesis of organ dysfunction in children with septicemia (12, 35) . In a murine cecal ligation and puncture model of septic shock, levels of IL-6 at 6 hrs after onset of sepsis were predictive of outcome (34) . Although the effect of IL-6 on cardiac myocytes has largely been assumed to be the result of transignaling from binding of IL-6 to soluble receptor in serum and subsequent activation through cell surface gp130 receptor, our data in both rat and human cardiac myocytes show a direct negative inotropic effect of IL-6 in the absence of the soluble receptor (12) , suggesting that classic signaling through a cell surface IL-6 receptor also occurs.
Our study has demonstrated that the myocardial depressant effects of IL-6 appear to be dependent on signaling through the p38MAPK pathway and that inactivation of p38MAPK abolishes this activity and restores sensitivity to the inotropic agent isoprenaline.
p38MAPK regulates a broad range of cellular responses, including inflammation, proliferation, apoptosis, cellular defense, and differentiation (37, 38) . Activation of p38MAPK has been demonstrated in myocardial, lung, and brain tissue in sepsis (39 -42) , suggesting that p38MAPK has widespread effects in the pathophysiology of multiorgan dysfunction in septic shock. Inhibition of p38MAPK has been shown to attenuate lipopolysaccharide-induced acute lung injury through downregulation of the nuclear factor B pathway (43) .
In animal models, the p38MAPK pathway has been shown to contribute to the cardiodepressant activity of tumor necrosis factor-␣ (17) and endotoxin (44) . During myocardial ischemia and reperfusion, p38MAPK activation induces myocyte apoptosis, increases expression of adhesion molecules, and reduces cardiac myofilament calcium sensitivity (45) . Furthermore, inhibition of p38MAPK prevents myocardial tumor necrosis factor-á expression and improves cardiac function and survival in endotoxemic rats (44) .
Our RNA expression studies in children with meningococcal sepsis has revealed elevated abundance of transcripts for genes that encode upstream activating factors for p38␣ MAPK (MAP3K7, MAP3K5, MAP2K4, and MAP2K6); the IL6 receptor; JAK2 and Akt as well as downstream mediators, including transcription factors (such as nuclear factor B and activating transcription factor), MAPK-activated protein kinases, and inflammatory cytokines such as IL-1␤. These data confirm that the p38MAPK pathway is highly activated in acute meningococcal sepsis in humans. Data from the Genomics of Pediatric Systemic Inflammatory Response Syndrome/Septic Shock Investigators confirms in a larger group of children with septic shock that the IL-6 and p38MAPK pathways are significantly dysregulated on admission to pediatric intensive care unit (46) .
We have demonstrated that the p38MAPK pathway is dysregulated in cardiac myocytes after exposure to IL-6 and that the negative inotropy of IL-6 is reversed by blockade of the p38MAPK pathway. Our data suggest that the p38MAPK pathway is of major importance in the development of inotrope-unresponsiveness both acutely and after a prolonged incubation time. The dramatic effect of inhibitors of p38MAPK not only in abolishing the myocardial depressant effect of IL-6 on cardiac contractility in vitro, but in restoring inotrope sensitivity, suggests that inhibition of p38MAPK may be of benefit in treatment of meningococcal shock, because the condition is characteristically associated with reduced inotrope responses and the requirement for . Genes with significantly elevated transcript levels (**) and genes with significantly decreased transcript levels (*) are highlighted. a Changes in transcript levels of differentially expressed genes associated with the p38MAPK pathway in rat cardiac myocytes exposed to interleukin 6. "logFC" is the log 2 fold difference between interleukin 6-treated and untreated cardiac myocytes. "adj.P.Val" is the associated p value before and after adjustment for multiple testing. Genes are ordered by the magnitude of the adjusted p value. escalating doses of catecholamines. Other inflammatory mediators known to have myocardial depressant effects such as the complement component C5a and the proinflammatory cytokine tumor necrosis factor-␣ have also been shown to activate the p38MAPK pathway (47, 48) .
An important limitation of our study is the unavailability of human septic myocardial tissue. Checchia et al (49) examined the effects of age on transcriptional responses to sepsis in the myocardium of young (6 wks) and old (20 months) septic mice. Genes of the IL-6 and p38MAPK pathway were among 53 significantly differentially expressed genes comparing young and old sepsis and sham groups of animals.
Because IL-6 is released in response to all bacterial infections, our findings may be relevant to the treatment of myocardial depression in other forms of septic shock. In children with septic shock of varying etiology (both Gram-positive and Gram-negative), Cvijanovich et al (50) identified the p38MAPK pathway being significantly upregulated. Furthermore, our findings may also be relevant to other forms of systemic inflammatory activation such as burns (51), ischemia-reperfusion (52) , and cardiopulmonary bypass (53, 54) , in which p38MAPK activation and its relation to multiorgan dysfunction is becoming increasingly clear. Inhibitors of the p38MAPK pathway are being investigated in animal and human studies of sepsis and other proinflammatory disease states (54 -58) . Modulation of up-or downstream regulators of this pathway could also be of interest therapeutically. Figure 4 . The p38 mitogen-activated protein kinase (MAPK) pathway is significantly dysregulated in blood from septic patients compared with healthy control subjects. A, Heat map of gene expression patterns in whole blood from meningococcal patients compared with control patients. Patterns of transcript abundance of genes involved in the p38MAPK pathway in whole-blood samples from 14 children with meningococcal sepsis compared with 23 healthy adults. Genes and subjects were organized using hierarchical clustering; each row represents a single gene and each column a single subject (sample). Black indicates the median level of transcript abundance; red indicates higher transcript abundance than the median; green, lower transcript abundance; and white, missing data. The genes in the heat map are listed in Supplemental Table 1 (see Supplemental Digital Content 1, http://links.lww.com/CCM/A243). B, Log-odds ratios of differentially expressed genes of the p38MAPK pathway in meningococcal patients compared with healthy children. The volcano plot arranges genes along dimensions of biological and statistical significance. The horizontal axis is the average log-fold difference between meningococcal patients and the healthy control subjects for genes of the p38MAPK pathway. The vertical axis is the log-odds ratio that the gene is differentially expressed and indicates the statistical evidence or reliability of the difference.
